WASHINGTON– Federal regulators have authorized emergency use of another COVID-19 treatment, the anti-inflammatory drug baricitinib, to be used in combination with a drug already used to treat severely ill, hospitalized patients.
The Food and Drug Administration on Thursday cleared the new use for Eli Lilly’s pill baricitinib plus remdesivir for hospitalized adults and children two years and older requiring oxygen or ventilation therapy.
Remdesivir is the first and only drug approved by FDA to treat COVID-19. The emergency clearance for baricitinib acts as a preliminary approval until more data is available showing the drug works for COVID-19.
The FDA said the drug combination appeared to reduce recovery time in hospitalized patients, compared to patients who received only remdesivir.
The agency said ongoing research will be needed to confirm the benefit.
Indianapolis-based Lilly already sells baricitinib as Olumiant to treat rheumatoid arthritis, the less common form of arthritis that occurs when the immune system attacks joints, causing inflammation. An overactive immune system also can lead to serious problems in coronavirus patients.
The FDA based its decision on a 1,000-patient study in which patients were randomly assigned to receive the drug combination– baricitinib plus remdesivir– or remdesivir plus a placebo. The study was conducted by the National Institutes of Health.
- (WTAJ) — Along with advising that vaccinated individuals begin wearing masks indoors, The Centers for Disease Control and Prevention (CDC) also updated their recommendations for COVID-19 testing as it relates to those who are vaccinated. The CDC now recommends that vaccinated individuals should get tested for COVID-19 after being exposed to the virus, even if […]
- Masks will now be required while indoors at military installations and other facilities controlled by the Department of Defense.
- After missing out on various high school activities like prom, sports, extracurriculars, concerts and more, students could finally see a light at the end of the tunnel.
- Cheyne Satter went from being a perfectly healthy 27-year-old to being debilitated by COVID.
- (NEXSTAR) — President Biden will call on "state, territorial, and local governments" to provide $100 payments to newly vaccinated Americans as part of an extra incentive to boost vaccination rates, the Treasury Department announced on Thursday. The cash reward for vaccination was one idea in Biden’s latest plan to boost lagging vaccination rates in many […]
- Virginia Gov. Ralph Northam says he recommends masks in indoor public settings, but is not going to require them at this time.
- District of Columbia Mayor Muriel Bowser is reinstating a mask mandate. People over the age of two will be required to wear a mask indoors, regardless of vaccination status.
- Northam reviewing mask policy options as Virginia reports 1,000 new daily COVID-19 cases for the first time since AprilVirginia reported more than 1,000 new COVID-19 cases Wednesday, the first time the commonwealth has hit that mark since late April.
- The understanding of how vaccinated people who are infected might spread the virus to others is changing.
- A map created by the Associated Press with data from Johns Hopkins University shows Louisiana, Arkansas and Missouri are being hit especially hard.